Baxter International - BAX Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BAX shares.
View BAX analyst ratings or view top-rated stocks.

10 equities research analysts have issued 12 month price objectives for Baxter International's shares. Their BAX share price forecasts range from $60.00 to $100.00. On average, they predict the company's stock price to reach $77.69 in the next year. This suggests a possible upside of 40.2% from the stock's current price.
View analysts price targets for BAX or view top-rated stocks among Wall Street analysts.

Baxter International's stock was trading at $85.84 on January 1st, 2022. Since then, BAX stock has decreased by 35.4% and is now trading at $55.41.
View the best growth stocks for 2022 here.

Baxter International saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 5,090,000 shares, an increase of 12.6% from the August 15th total of 4,520,000 shares. Based on an average daily volume of 3,180,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 1.0% of the company's shares are sold short.
View Baxter International's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our BAX earnings forecast.

Baxter International will be holding an earnings conference call on Thursday, October 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Baxter International Inc. (NYSE:BAX) posted its earnings results on Thursday, July, 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, meeting the consensus estimate of $0.87. The medical instruments supplier earned $3.75 billion during the quarter, compared to the consensus estimate of $3.88 billion. Baxter International had a trailing twelve-month return on equity of 21.75% and a net margin of 7.12%. The business's quarterly revenue was up 20.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.80 earnings per share.
Read the conference call transcript.

Baxter International declared a quarterly dividend on Tuesday, July 12th. Shareholders of record on Friday, September 2nd will be paid a dividend of $0.29 per share on Monday, October 3rd. This represents a $1.16 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, September 1st.
Read our dividend analysis for BAX.

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.10%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 58.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAX will have a dividend payout ratio of 29.90% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BAX.

Baxter International updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $3.60-$3.70 for the period, compared to the consensus estimate of $4.13. The company issued revenue guidance of -.

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include California Public Employees Retirement System (0.72%), Caisse DE Depot ET Placement DU Quebec (0.72%), UBS Asset Management Americas Inc. (0.43%), Amundi (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.30%) and Cooke & Bieler LP (0.26%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends.

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAX stock can currently be purchased for approximately $55.41.

Baxter International (NYSE:BAX) has a market capitalization of $27.91 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or $2.00 on an earnings per share basis.

The company employs 60,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.